Is PBYI stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Puma Biotechnology Inc had a stock price of $224.08. If you invested back then, your return now would be a loss of $-221.24 per share or -98.73%
Yes, the average daily trading liquidity for Puma Biotechnology Inc is $1.12 million. You should therefore be able to get in and out of your positions relatively fast.
Puma Biotechnology Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.39, the company's ability to pay off the debt is normal. Puma Biotechnology Inc has a good net profit margin of 10.60% and should have high tolerances against inflation.
We have calculated the inflation risk for Puma Biotechnology Inc to be low [0.4 out of 1]